Mode
Text Size
Log in / Sign up
N/A Completed N=39 Treatment

A Novel Approach for Thyroplasty Type 1, With Prolene Mesh. A Prospective Study.

vocal cord paralysis · Phonasthenia · Presbylarynges · Idiopathic Vocal Cord Paralysis
Source: ClinicalTrials.gov NCT04458818 ↗
Enrolled (actual)
39
Serious AEs
0.0%
Results posted
Apr 2021
Primary outcomePrimary: Change in Mean Phonation Time — 7.74; 14.08 seconds

Summary

Larynx performs important functions of the aero-digestive tract, it has vital role in control of breathing, phonation, deglutition and protection of lower respiratory tract from aspiration. Vocal cord paralysis is a common and at times debilitating laryngeal dysfunction that has great social and economic impact on patients life. Medialization thyroplasty (MT), if done accurately and up to the expectations of the patient is very rewarding. However different materials with some modifications in the technique of the classical Isshiki type 1 thyroplasty is in practice, each with its own profile of benefits and disadvantages. Most of them are costly and out of reach of general population. In this regard, we aim to test a prolene mesh implant, which is easily available and can be placed with relative ease.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Mean Phonation Time
7.74; 14.08
PRIMARY
Change in Maximum Words Count
11.33; 18.28
PRIMARY
Change in Voice Quality on Visual Analogue Score
4.77; 7.64

Eligibility Criteria

Inclusion Criteria

  • Age more than 15 years
  • Vocal cord paralysis

Exclusion Criteria

  • Patients with neoplasms
  • Trauma
  • Muscular dystrophies
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04458818). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search